Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 12—December 2009

Cross-sectional Survey of Hantavirus Infection, Brazil

Jean E. LimongiComments to Author , Fabíola C. da Costa, Rogério M.C. Pinto, Renata C. de Oliveira, Camila Bragagnolo, Elba R.S. Lemos, Márcia B.C. de Paula, Adalberto A. Pajuaba Neto, and Marcelo S. Ferreira
Author affiliations: Federal University of Uberlândia, Uberlândia, Minas Gerais, Brazil (J.E Limongi, F.C. da Costa, R.M.C. Pinto, M.S. Ferreira); Department of Public Health, Uberlândia (J.E Limongi, M.B.C. de Paula, A.A. Pajuaba Neto); Oswaldo Cruz Foundation, Rio de Janeiro, Brazil (R.C. de Oliveira, C. Bragagnolo, E.R.S. Lemos)

Main Article

Table 2

Incidence of hantavirus pulmonary syndrome and hantavirus antibody prevalence in the municipality of Uberlândia, Brazil, according to geographic area, 2006*

Variable Area
p value† OR (95% CI)
Overall Rural Periurban
Cases‡ 13 5 8 0.24 1.92 (0.63–5.90)
Population 71,122 17,406 53,716§
Cumulative incidence, 1998–2005 (×104)

Antibody positive 12 8 4 0.38 0.49 (0.14–1.65)
Sample 400 200 200
Prevalence, % (95% CI)† 3.0 (1.3–4.7) 4.0 (1.3–6.7) 2.0 (0.1–3.9)

*OR, odds ratio; CI, confidence interval.
†Rural versus periurban. Determined by using 2-tailed Fisher exact or binomial tests for 2 proportions.
‡Limongi et al. (3).
§Total population of the southern part of the periurban area.

Main Article

  1. Suzuki  A, Bisordi  I, Levis  S, Garcia  J, Pereira  LE, Souza  RP, Identifying rodent hantavirus reservoirs, Brazil. Emerg Infect Dis. 2004;10:212734.PubMedGoogle Scholar
  2. Figueiredo  LT, Moreli  ML, Borges  AA, Figueiredo  GG, Souza  RL, Aquino  VH. Expression of a hantavirus N protein and its efficacy as antigen in immune assays. Braz J Med Biol Res. 2008;41:5969. DOIPubMedGoogle Scholar
  3. Limongi  JE, Costa  FC, Paula  MB, Pinto  RM, Oliveira  ML, Neto  AA, Hantavirus cardiopulmonary syndrome in the Triângulo Mineiro and Alto Paranaíba regions, State of Minas Gerais, 1998–2005: clinical-epidemiological aspects of 23 cases [in Portuguese]. Rev Soc Bras Med Trop. 2007;40:2959. DOIPubMedGoogle Scholar
  4. Mascarenhas-Batista  AV, Rosa  ES, Ksiazek  TG, Rosa  AP, Leduc  JW, Pinheiro  F, Antibodies anti-hantavirus in schoolchildren in Salvador, Bahia State, Brazil [in Portuguese]. Rev Soc Bras Med Trop. 1998;31:43340. DOIPubMedGoogle Scholar
  5. Armien  B, Pascale  JM, Bayard  V, Munoz  C, Mosca  I, Guerrero  G, High seroprevalence of hantavirus infection on the Azuero Peninsula of Panama. Am J Trop Med Hyg. 2004;70:6827.PubMedGoogle Scholar
  6. Máttar  S, Parra  M. Serologic evidence of hantavirus infection in humans, Colombia. Emerg Infect Dis. 2004;10:22634.PubMedGoogle Scholar
  7. Santos  ED, Garrett  DO. Evaluation of the hantavirus surveillance in Brazil [in Portuguese]. Epidemiologia e Serviços de Saúde. 2005;14:1531.
  8. Ferrer  JF, Jonsson  CB, Esteban  E, Galligan  D, Basombrio  MA, Peralta-Ramos  M, High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg. 1998;59:43844.PubMedGoogle Scholar
  9. Campos  GM, Sousa  RL, Badra  SJ, Pane  C, Gomes  UA, Figueiredo  LT. Serological survey of hantavirus infection in Jardinopolis County, Brazil. J Med Virol. 2003;71:41722. DOIPubMedGoogle Scholar
  10. Pini  N. Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis. 2004;17:42731.Medline DOIPubMedGoogle Scholar
  11. Täger Frey  MT, Vial  PC, Castillo  CH, Godoy  PM, Hjelle  B, Ferrés  MG. Hantavirus prevalence in the IX Region of Chile. Emerg Infect Dis. 2003;9:82732.PubMedGoogle Scholar

Main Article

Page created: December 09, 2010
Page updated: December 09, 2010
Page reviewed: December 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.